Zurcher Kantonalbank Zurich Cantonalbank Has $346,000 Position in Evolent Health, Inc (NYSE:EVH)

Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Evolent Health, Inc (NYSE:EVH) by 18.6% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 36,498 shares of the technology company’s stock after acquiring an additional 5,712 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Evolent Health were worth $346,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Signaturefd LLC raised its holdings in Evolent Health by 400.6% during the first quarter. Signaturefd LLC now owns 7,043 shares of the technology company’s stock worth $67,000 after buying an additional 5,636 shares during the last quarter. State of Wyoming acquired a new position in Evolent Health during the fourth quarter worth $95,000. GAMMA Investing LLC raised its holdings in Evolent Health by 5,036.4% during the first quarter. GAMMA Investing LLC now owns 9,451 shares of the technology company’s stock worth $90,000 after buying an additional 9,267 shares during the last quarter. Ethic Inc. acquired a new position in Evolent Health during the fourth quarter worth $113,000. Finally, Unified Investment Management acquired a new position in Evolent Health during the first quarter worth $104,000.

Evolent Health Price Performance

EVH opened at $9.00 on Friday. The firm has a market cap of $1.06 billion, a P/E ratio of -5.59 and a beta of 0.82. The firm has a 50-day moving average of $9.93 and a 200 day moving average of $9.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.98 and a current ratio of 0.98. Evolent Health, Inc has a fifty-two week low of $7.06 and a fifty-two week high of $33.63.

Evolent Health (NYSE:EVH) last posted its quarterly earnings results on Thursday, August 7th. The technology company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.20). The company had revenue of $444.33 million for the quarter, compared to the consensus estimate of $459.43 million. Evolent Health had a negative net margin of 5.94% and a positive return on equity of 1.78%. Evolent Health’s quarterly revenue was down 31.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.30 EPS. On average, research analysts expect that Evolent Health, Inc will post 0.08 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. UBS Group upped their price objective on shares of Evolent Health from $14.00 to $15.00 and gave the stock a “buy” rating in a report on Friday, May 9th. JMP Securities restated a “market outperform” rating and set a $13.00 price objective on shares of Evolent Health in a report on Friday, June 20th. Needham & Company LLC reiterated a “buy” rating and issued a $15.00 target price on shares of Evolent Health in a research note on Tuesday, May 13th. Finally, Truist Financial upped their target price on shares of Evolent Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Thursday, July 17th. One equities research analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $17.93.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.